![Anthony Polverino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Polverino
Direktor/Vorstandsmitglied bei
BRAINSTORM CELL THERAPEUTICS INC.
Vermögen: 19 298 $ am 31.05.2026
Profil
Dr. Anthony J.
Polverino is an Independent Director at Brainstorm Cell Therapeutics, Inc. He is on the Board of Directors at Brainstorm Cell Therapeutics, Inc. Dr. Polverino was previously employed as a Chief Scientific Officer & EVP-Early Development by Zymeworks BC, Inc., a Chief Scientific Officer by Kite Pharma, Inc., an Executive Director-Therapeutic Innovation Unit by Amgen, Inc., and a Chief Scientific Officer & EVP-Early Development by Zymeworks, Inc. He received his undergraduate degree from the University of Adelaide and a doctorate degree from Flinders University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.02.2026 | 25’730 ( 0.23% ) | 19 298 $ | 31.05.2026 |
Aktive Positionen von Anthony Polverino
| Unternehmen | Position | Beginn |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 05.02.2018 |
Ehemalige bekannte Positionen von Anthony Polverino
| Unternehmen | Position | Ende |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Technik-/Wissenschafts-/F&E-Leiter | 19.01.2022 |
| KITE PHARMA INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
| ZYMEWORKS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Ausbildung von Anthony Polverino
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
42
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flinders University
 Flinders University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
